Literature DB >> 34282187

The role of FOSL1 in stem-like cell reprogramming processes.

Valeria Pecce1, Antonella Verrienti2, Giulia Fiscon3, Marialuisa Sponziello2, Federica Conte4, Luana Abballe5, Cosimo Durante2, Lorenzo Farina6, Sebastiano Filetti7, Paola Paci4,6.   

Abstract

Cancer stem-like cells (CSCs) have self-renewal abilities responsible for cancer progression, therapy resistance, and metastatic growth. The glioblastoma stem-like cells are the most studied among CSC populations. A recent study identified four transcription factors (SOX2, SALL2, OLIG2, and POU3F2) as the minimal core sufficient to reprogram differentiated glioblastoma (GBM) cells into stem-like cells. Transcriptomic data of GBM tissues and cell lines from two different datasets were then analyzed by the SWItch Miner (SWIM), a network-based software, and FOSL1 was identified as a putative regulator of the previously identified minimal core. Herein, we selected NTERA-2 and HEK293T cells to perform an in vitro study to investigate the role of FOSL1 in the reprogramming mechanisms. We transfected the two cell lines with a constitutive FOSL1 cDNA plasmid. We demonstrated that FOSL1 directly regulates the four transcription factors binding their promoter regions, is involved in the deregulation of several stemness markers, and reduces the cells' ability to generate aggregates increasing the extracellular matrix component FN1. Although further experiments are necessary, our data suggest that FOSL1 reprograms the stemness by regulating the core of the four transcription factors.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34282187     DOI: 10.1038/s41598-021-94072-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  29 in total

1.  Integrin alpha 6 regulates glioblastoma stem cells.

Authors:  Justin D Lathia; Joseph Gallagher; John M Heddleston; Jialiang Wang; Christine E Eyler; Jennifer Macswords; Qiulian Wu; Amit Vasanji; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

2.  A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

Authors:  Ruihuan Chen; Merry C Nishimura; Stephanie M Bumbaca; Samir Kharbanda; William F Forrest; Ian M Kasman; Joan M Greve; Robert H Soriano; Laurie L Gilmour; Celina Sanchez Rivers; Zora Modrusan; Serban Nacu; Steve Guerrero; Kyle A Edgar; Jeffrey J Wallin; Katrin Lamszus; Manfred Westphal; Susanne Heim; C David James; Scott R VandenBerg; Joseph F Costello; Scott Moorefield; Cynthia J Cowdrey; Michael Prados; Heidi S Phillips
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

Review 3.  Cancer stem cells.

Authors:  Craig T Jordan; Monica L Guzman; Mark Noble
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

4.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

5.  The double dissociation of short-term memory for lists and sentences. Evidence from aphasia.

Authors:  R A McCarthy; E K Warrington
Journal:  Brain       Date:  1987-12       Impact factor: 13.501

6.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Authors:  D Bonnet; J E Dick
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

7.  TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma.

Authors:  Judit Anido; Andrea Sáez-Borderías; Alba Gonzàlez-Juncà; Laura Rodón; Gerard Folch; Maria A Carmona; Rosa M Prieto-Sánchez; Ignasi Barba; Elena Martínez-Sáez; Ludmila Prudkin; Isabel Cuartas; Carolina Raventós; Francisco Martínez-Ricarte; M Antonia Poca; David García-Dorado; Michael M Lahn; Jonathan M Yingling; Jordi Rodón; Juan Sahuquillo; José Baselga; Joan Seoane
Journal:  Cancer Cell       Date:  2010-12-14       Impact factor: 31.743

8.  SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.

Authors:  Myung Jin Son; Kevin Woolard; Do-Hyun Nam; Jeongwu Lee; Howard A Fine
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

Review 9.  Cancer stem cells in nervous system tumors.

Authors:  Sheila K Singh; Ian D Clarke; Takuichiro Hide; Peter B Dirks
Journal:  Oncogene       Date:  2004-09-20       Impact factor: 9.867

Review 10.  Stem cell fate in cancer growth, progression and therapy resistance.

Authors:  Nikki K Lytle; Alison G Barber; Tannishtha Reya
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

View more
  3 in total

1.  FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis.

Authors:  Zhengxin Chen; Shuai Wang; Hai-Lin Li; Hui Luo; Xiaoting Wu; Jiacheng Lu; Hong-Wei Wang; Yuanyuan Chen; Dan Chen; Wen-Ting Wu; Shuyu Zhang; Qiongqiong He; Daru Lu; Ning Liu; Yongping You; Wei Wu; Huibo Wang
Journal:  Mol Ther       Date:  2022-03-26       Impact factor: 12.910

Review 2.  SALL Proteins; Common and Antagonistic Roles in Cancer.

Authors:  Claudia Álvarez; Aracelly Quiroz; Diego Benítez-Riquelme; Elizabeth Riffo; Ariel F Castro; Roxana Pincheira
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

3.  Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas.

Authors:  Zijian Zhou; JinHong Wei; Zeruo Yang; Yue Bao; Wenbo Jiang; Bin Lu; Weimin Wang; Luo Li
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.